As of 2026-08-12, the Fair Value of Viracta Therapeutics Inc (VIRX) is -43.18 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 USD, the upside of Viracta Therapeutics Inc is -55,598.78%.
With the market price of 0.08 USD and our fair value calculation, Viracta Therapeutics Inc (VIRX) is not a good investment. Investing in VIRX stocks now will result in a potential loss of 55,598.78%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -23.33 | -21.61 | -114.76 | -49.20 | -51.06 | -51.99 |
| YoY growth | 12.36% | 7.37% | -431.05% | 57.13% | -3.78% | -71.59% |
| Market Cap (mil) | 0.39 |
| P/E | |
| Forward P/E |
| EPS | -8.64 |
| Avg earnings growth rate | -71.59% |
| TTM earnings | -43.29 |